HealthTech
Alibaba DAMO unveils AI models for cancer and abdominal CT
Alibaba DAMO Academy has published research on EAGLE for esophageal cancer screening and RADAR for broad abdominal CT interpretation. Both remain research systems rather than approved clinical products.
CUHK develops AI magnetic tracking for miniature medical robots
CUHK researchers have developed an AI-driven magnetic tracking system that localizes millimeter-scale wireless medical robots during magnetic actuation and enables closed-loop navigation.
Mayo Clinic Laboratories invests in Pathology Asia and LifeStrands Genomics
Mayo Clinic Laboratories has invested in Singapore-based Pathology Asia Holdings and LifeStrands Genomics to expand advanced diagnostics and precision medicine across Asia Pacific.
Japan’s Ricoh invests in Singapore mental-health platform Intellect via $20M venture fund
Japan's Ricoh has invested in Intellect, a Singapore-based workplace mental-health platform, through its corporate venture-capital fund, in the fund's first deal.
Japan’s Mitsui taps Singapore’s Oncoshot for AI oncology-data platform across IHH hospital network
Japan's Mitsui & Co. will collaborate with Singapore's Oncoshot to use the firm's AI platform for analyzing cancer-clinical data, aiming to expand oncology research across the hospital network of Malaysia's IHH Healthcare.
KKR to buy minority stake in Malaysia’s Avisena Healthcare, to expand flagship hospitals
The United States-based investment firm KKR has agreed to buy a minority stake in Malaysia's Avisena Healthcare, a private hospital operator.
Nebius’ Dr. Ilya Burkov on making safe healthcare AI the easy option [Q&A]
Dr. Ilya Burkov of Nebius discusses shadow AI, local validation, patient anxiety, and why clinicians must remain accountable for high-stakes decisions.
Singapore’s Bioactivx raises $3M for synthetic skin-substitute wound-care technology
Bioactivx, a Singapore deep-tech startup developing synthetic materials for wound care, has raised $3 million in a pre-Series A funding round co-led by the venture firm Cocoon Capital and Martin Krupp, managing director of the Swiss family office ContInvest, with other new and existing investors.
Singapore’s biotechnology firm K2 Therapeutics raises $50M in seed financing from MPM BioImpact
K2 Therapeutics, a Singapore-based biotechnology company, has raised $50 million in seed financing from MPM BioImpact, the U.S. investment firm that founded the company in 2024.
China’s Ant Group upgrades physician platform into AI workstation “AQ for Doctor” with 300,000 verified doctors
China's Ant Group, the operator of Alipay, has upgraded its physician platform "Haodf for Doctor" into "AQ for Doctor," an AI-powered workstation for physicians covering online consultations, patient management, clinical decision support, and medical research.
